Dear Sir,
In their original paper, Modan et al. [1] stated "the association with degree of overweight was non-linear, with threshold effects of BMI ~> 31 for Type 2 diabetes, which were evident in all age, sex and blood pressure categories and in three of our four ethnic groups". In their reply [2] to my letter, they retract this somewhat, stating that "there is a continuous increase throughout the body mass index range with a sharp increase when body mass index reaches values above 31 -evident in both Type 1 and Type 2 diabetes". Do they really mean Type 1 ? However, I now realise that neither position can be inferred from the data presented, for it does not allow for any effects of age upon the prevalence of diabetes at the second examination when glucose tolerance tests were performed, although the age range at the first examination was wide -from 40-70 years. It is true that past BMI significantly related to diabetes prevalence independently of age in their multiple logistic regression, but this does not provide information on the shape of the association with BMI, i.e. linear or non-linear. If the latter, then logistic regression may not be appropriate anyway.
The data of Westlund and Nicolaysen [3] were based on a narrow age range (40-49 years) and indicate a non-linear association between relative body weight and 10-year incidence of diabetes. However, given the small numbers it might not be possible to determine whether the non-linear association was indeed a threshold phenomenon. In the Gothenburg Study [4] a cohort of men aged 54years was studied for 13 years, during which 37 (6.3%) developed diabetes. When incidence was plotted against the percentiles of distribution of BMI (and waist-hip ratio) the relationship was non-linear. There were no cases of diabetes from the lowest quintile of BMI distribution, but over the three intermediate quintiles, there was no observable trend in incidence. Incidence was approximately doubled above the 80th centile of BMI.
In the Pima Indian incidence study [5] there was only one case from amongst those with BMI < 20, but age and sex adjusted rates were not significantly different between BMI categories 20-25 and 25-30.
It is possible to perceive some consensus from these several studies -that the risk of Type 2 diabetes is very different at the extremes of the distribution of BMI but that over a fairly wide range between those extremes there is little or no trend in risk, the implication being that over this range factors other than adiposity are determinants. Modan et al. [2] suggest ihat physical activity may be one of these. We, however, were unable to find a relationship of leisure time activity and either glucose tolerance or newly diagnosed Type 2 diabetes in the men in the Whitehall Study [6] .
Yours sincerely, R. J. Jarrett 
Response from the authors
Dear Dr. Berger~ 1) There seems to be a misunderstanding on the part of Dr. Jarrett regarding the term "non linear" as used by us in our study to describe the relationship of the prevalence of Type 2 diabetes with BMI. We used it to describe an initial milder continuous increase and then a sharper one. Both increases were significant, as stated in Tables 3 and  4 of that paper [1] .
2) The sentence "evident in both Type 1 and Type 2 diabetes" was an inadvertent editorial change (no galley proofs are forwarded for letters). Clearly our study refers to Type 2 diabetes alone.
3) Although the rate of diabetes increases with age in all BMI categories, the above described relationship with BMI occurs in all ages and thus cannot be accounted for by the confounding effect of age (Table 1) . 5) Our questionnaire referred to all types of habitual activity, including work time as well as at leisure time. The rate of persons involved in any type of sport was minimal. "High" physical activity was defined as activity score in the highest tertile of the study group. The score consisted of the weekly number of hours spent in moderate activity (heavy activity was not reported by any of the 502 individuals constituting the subsample interviewed for dietary intake and physical activity) + half of the hours spent in light activity defined according to the Committee on Dietary Allowances [2] . Using this crude measure, and accounting for age, BMI and total caloric intake, the risk for Type 2 diabetes for "highly" active individuals of both sexes was 0.67 with 90% confidence limits 0.4%0.96 (p = 0.04) [3] . This was validated by significantly lower insulin response in the "highly" active individuals in all sex and BMI categories (unpublished data).
Yours sincerely M. Modan, A. Karasik and H. Halkin rum C-peptide in Type 1 diabetic patients and their siblings. We found in this study that DR4+ diabetic patients showed better preservation of their C-peptide blood concentrations than diabetic patients with other HLA types. It is difficult to reconcile these findings with the Ludvigsson et al. [1] results showing that DR3 + diabetic patients have a milder disease. Both our study [2] (not prospective) and the Ludvigsson et al. study [11 (based on questionnaire data and multicenter) have weaknesses. Thus, this subject needs independent confirmation.
The observation by Ludvigsson et al. [1] that 15patients were DR4-, DR3 -, DR2+, presumably mostly from France, is of considerable interest. We have recently shown that there is a third HLArelated susceptibility axis for diabetes (in addition to the DR3 -and DR4-related axes) defined by homozygous typing cells (Dw) and restriction fragment length polymorphisms which is part of Dtl2-LD-MN2 as well as DRI-Dwl haplotypes [3] . Those 15 patients presumably carried one or both of these haplotypes. 
Type I (insulin-dependent) diabetes and the question of heterogeneity
Dear Sir, I read with interest the report entitled "HLA-DR3 is associated with a more slowly progressive form of Type I (insulin-dependent) diabetes" by Ludvigsson et al. [1] . Since many of those interested in the causes of Type I diabetes mellitus believe in the likelihood of genetic heterogeneity, studies attempting to correlate phenotypes with genetic markers are welcome and may shed light on this important question. Unfortunately, most, if not all, claims of such correlations have lacked adequate confirmation. This confusing state of affairs has involved age of onset and other clinical parameters, as well as immunological indicators such as islet cell antibodies, insulin antibodies, etc.
The results of Ludvigsson et al. [1] seem to be in apparent conflict with data we reported recently [2] from cross sectional studies of se-
Hyperkalaemia after interruption of CSII
Dear Sir, It has recently been suggested that the serum potassium concentrations on admission to hospital with ketoacidosis may be higher in patients treated by continuous subcutaneous insulin infusion (CSII) compared to those receiving conventional injection therapy [1] .
In consideration of the possible risks of hyperkalaemia, it may be of interest to reconsider the study which we published in Diabetologia in 1982 [2] , where CSII was deliberately interrupted for 9 h in 9 resting and fasting Type I (insulin-dependent) diabetic patients. We did not record plasma potassium levels at the time of the study, but we have now measured by flame photometry the values on the stored plasma samples (kept at -40 °C) from the 7 C-peptide negative patients (all male, mean + SD age 33 + 12 years, duration of diabetes 13 + 6 years). Figure I shows the results, together with the changes in plasma glucose, blood 3-hydroxybutyrate and plasma free insulin concentration, which were assayed at the time of the study. Mean plasma potassium levels increased throughout the 9 h and were significantly different from baseline at all time points from 6 h (p < 0.01, t-test) until the end of the experiment (p < 0.01).
